Mirae Asset Global ETFs Holdings
AKRO

Mirae Asset Global ETFs Holdings’s Akero Therapeutics AKRO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,276
Closed -$1.87M – 3110
2025
Q3 		$1.87M Sell
39,276
-3,585
-8% -$174K ﹤0.01% 1174
2025
Q2 		$2.3M Sell
42,861
-4,957
-10% -$225K ﹤0.01% 1032
2025
Q1 		$1.94M Buy
47,818
+6,376
+15% +$270K ﹤0.01% 1157
2024
Q4 		$1.15M Buy
41,442
+637
+2% +$19.3K ﹤0.01% 1477
2024
Q3 		$1.17M Buy
40,805
+5,336
+15% +$139K ﹤0.01% 1451
2024
Q2 		$832K Buy
+35,469
New +$759K ﹤0.01% 1562

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AKRO Position: Q4 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 39,276 shares — an estimated $1.87M sold.

Mirae Asset Global ETFs Holdings first reported a position in AKRO in Q2 2024 and held it in 6 quarters. The position peaked at $2.3M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 39,276 Akero Therapeutics shares in Q4 2025, an estimated $1.87M.
  • Mirae Asset Global ETFs Holdings first reported a position in Akero Therapeutics in Q2 2024 and held it in 6 quarters.
  • Mirae Asset Global ETFs Holdings's Akero Therapeutics position peaked at $2.3M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.